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Thoracoscopic lung biopsyAbstract Introduction: Visceral pleural biopsy and peripheral lung biopsy can be undertaken at
the same time as parietal pleural biopsy during medical thoracoscopy, with or without coexistence
of a pleural effusion with lung disease.
Objective: To assess the accuracy and safety of medical thoracoscopy for the evaluation of
peripheral parenchymal pulmonary lesions.
Patients: We studied 15 patients with peripheral parenchymal pulmonary disease, the cause of
which had not been determined after initial investigations, including needle biopsy and thoraco-
centesis if pleural effusion is present. Two patients have solitary peripheral lesions while thirteen
have diffuse pathology. Seven patients have pleural effusion in addition to parenchymal lesions.
Methods: Only one patient had thoracoscopy under general anaesthesia while the remaining
fourteen were given local anaesthesia with mild sedation. Visually directed biopsies were taken from
the lung using electrocautery in all patients. Biopsies were taken also from the parietal pleura in
only seven patients.
Measurements: We recorded clinical characteristics, laboratory data, ﬁndings and duration of
thoracoscopy, and any complications associated with the procedure.
Results: A deﬁnitive diagnosis was established in 12 patients: 4 patients had primary bron-
chogenic carcinoma while 5 patients had metastases. Only 3 patients had benign parenchymal dis-
ease. Overall, thoracoscopy had a sensitivity of 80% for the diagnosis of peripheral parenchymal
pulmonary lesions. Thoracoscopy was well tolerated under local anaesthesia and entailed hospital-
ization for less than 48 h in most cases. No deaths occurred, although 6.7% of patients had major
complications, and 20% had minor complications.
Conclusions: Among patients with peripheral parenchymal pulmonary lesions remaining undiag-
nosed after usual initial investigation and even transthoracic needle biopsies, thoracoscopy done
under local anaesthesia is a rapid, safe, and well-tolerated procedure with an excellent diagnostic
yield that is equivalent to that of thoracotomy.
ª 2015 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis.
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The pleura is the serous membrane that covers the lung par-
enchyma, the mediastinum, the diaphragm and the rib cage.
This structure is divided into the visceral pleura and the
parietal pleura. The visceral pleura covers the lung parench-
yma, not only at its points of contact with the chest wall,
diaphragm and mediastinum but also in the inter-lobar ﬁs-
sures. The parietal pleura lines the inside of the thoracic cav-
ity and is subdivided, according to the intrathoracic surfaces
that it lines, into the costal, mediastinal and diaphragmatic
parietal pleura [1,2].
Thoracoscopy was ﬁrst done by Jacobeus in 1910, primarily
to break adhesions to induce artiﬁcial pneumothorax in tuber-
culous patients using a cystoscope [3,4]. Currently, the most
common indications for thoracoscopy include diagnosis of
the unknown exudative effusion, staging of malignant
mesothelioma or bronchogenic carcinoma, and treatment of
malignant or other recurrent effusions or empyema. Other less
common indications include, taking biopsies from the dia-
phragm, lung, mediastinum and pericardium, resection of
small peripheral lung lesions treatment of spontaneous pneu-
mothorax, sympathectomy for palmar and axillary
hyperhydrosis, resection of mediastinal masses and treatment
of resistant pericardial effusion [5].
Diffuse lung disease with involvement of the lung periph-
ery, has been an area of application of this technique in the
past, and was used recently when a conclusive diagnosis could
not be obtained by a less invasive method, [6–8] e.g. bron-
choalveolar lavage (BAL) and transbronchial biopsy (TBB).
Various diseases, such as granulomatous diseases [9] have been
studied in particular sarcoidosis and invasive mycosis, idio-
pathic interstitial pneumonias, bronchoalveolar carcinoma,
carcinomatous lymphangitis and histiocytosis X. The same
occurred for the diagnosis of localized lung disease and chest
wall lesions, though used infrequently, as demonstrated by
the literature sometimes preceded by transthoracic needle
aspiration.
Surgical lung biopsy, on the other hand, is an important
diagnostic procedure [10,11] though its related morbidity and
mortality have limited most of its indications to the failure
of other closed techniques, or to clinical situations where large
amounts of tissue are required at once.
Forceps lung biopsy during thoracoscopy under local
anaesthesia has been used for many years by pulmonologists
and has been frequently described as an integral technique of
medical thoracoscopy [12].Patients and methods
This study included 15 patients with peripheral parenchymal
lung lesions admitted to the chest department, Alexandria
main university hospital in the period between May and
December 2013. All patients had documented peripheral
parenchymal lung lesions of undetermined etiology. The pro-
cedure was contra-indicated in patients with one of the follow-
ing ﬁndings: coagulation deﬁcit (prothrombin level <50% or
platelet count <70,000 cells mm), severe respiratory insufﬁ-
ciency (arterial oxygen tension <60 mmHg), arterial carbon
dioxide tension (Pa, CO2) (>60 mmHg); mechanicalventilation; radiological signs suggesting important pleural
adhesions or major bullous degeneration of the lung.
Medical rigid thoracoscopy
Thoracoscopic examination was done using rigid thoracoscopy
[KARL STORZ HOPKINS Straight Forward Tele-scope 0
with parallel eyepiece diameter 10 mm, length 27 cm, autocla-
vable, ﬁberoptic light transmission incorporated with a 6 mm
instrument channel, Trocar size 11 mm consisting of Trocar
only with blunt tip Cannula, Click line BLAKESLEY
Dissecting and Biopsy Forceps, rotating, with a connector
pin for unipolar coagulation, size5 mm, length43 cm, single
action jaws].
Patients usually are breathing spontaneously, without
intubation, under conscious sedation with either midazolam
or propofol. Occasionally, assisted ventilation using a propofol
infusion via a single lumen endotracheal tube is used for better
analgesia; an anaesthesiologist’s input may be needed in such a
scenario.
In cases without pleural effusion, we used the method
described by BOUTIN and coworkers. A pneumothorax was
induced by the introduction of 600 mL of air into the pleural
space through a smooth ended pleural needle before skin
incision.
After raising a 2 cm subcutaneous wheal and anaesthetizing
the skin, subcutaneous tissues, muscle planes, rib periosteum
and parietal pleura by about 30 cc of 2% lidocaine. A 2 cm
transverse skin incision was made by a scalpel parallel to the
rib along the intercostal space chosen for tube insertion in
the wheal. Blunt dissection of the intercostal tissues was per-
formed by spreading a straight Kelly clamp both parallel
and perpendicular to the underlying muscles which were sepa-
rated and the parietal pleura was gently palpated by the index
ﬁnger and was penetrated by the Kelly clamp. The trocar is
inserted with the release valve open.
After drainage of the ﬂuid, rigid thoracoscopy was intro-
duced through the trocar into the pleural space. The parietal
pleura including the costal, diaphragmatic sometimes mediasti-
nal pleura as well as the visceral pleura were thoroughly exam-
ined for any lesions such as nodules, plaques, adhesions,
thickening, mottling or anthracosis. Multiple forceps biopsies
were taken from the visceral pleura and lung by a coagulating
forceps connected to electrocautery set at 60–100 W can
coagulate and seal the cut surface. Multiple forceps biopsies
were taken also from any suspicious gross pathological lesion
in the parietal pleura if present. The biopsies were then sent for
histopathological diagnosis.
Close observation for any complication was carried out and
recorded. The complications were then managed.
Results
See Figs. 1–6 and Tables 1 and 2.
Discussion
In the present study, the mean age of the patients was
52.47 ± 14.75 years, about 86.6% of patients were above
40 years. This mean age group was found to be comparable
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
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Table 1 Prethoracoscopic evaluation of candidate patients.
No. %
Age (years)
650 6 40.0
>50 9 60.0
Min.–Max. 18.0–68.0
Mean ± SD 52.47 ± 14.75
Median 52.0
Smoking (pack year index)
Min.–Max. 0.0–60.0
Mean ± SD 20.67 ± 24.34
Median 10
Sex
Male 10 66.7
Female 5 33.3
Pleural eﬀusion 6 40.0
Right 3 20.0
Left 3 20.0
Solitary parenchymal lesion 3 20.0
Diﬀuse pathology 11 73.3
Consolidation 4 26.7
Nodules 11 73.3
Mass 6 40.0
GGO 2 13.3
Transthoracic needle biopsies before thoracoscopy 6 40.0
Bronchoscopy before thoracoscopy 6 40.0
Table 2 Results of thoracoscopy (ﬁndings, histopathology,
complications).
No. %
Thoracoscopic
ﬁndings
Pleural eﬀusion 6 40.0
Visceral pleural aﬀection 15 100.0
Parietal pleural aﬀection 6 40.0
Side
Right 7 46.7
Left 8 53.3
Mass (es) 3 20.0
Nodules 14 93.3
Plaques 2 13.3
Adhesions 2 13.3
Anthracosis 6 40.0
Histopathology Metastases 5 33.33
BAC 2 13.33
Other types of bronchogenic
Carcinoma
2 13.33
ILD 3 20.0
Inconclusive 3 20.0
Complications Bronchopleural ﬁstula 1 6.7
Surgical emphysema 2 13.4
Wound infection 1 6.7
Empyema 0 0.0
GGO: ground glass opacities, BAC: bronchioloalveolar carcinoma,
ILD: interstitial lung disease.
712 E. Hatata et al.with the mean ages of the patients in previous similar studies;
which varied from 16.7 to 52.3 years [13–17].
All the patients in the present study were symptomatic at
the time of referral. The main presenting symptom was dysp-
nea (100% of patients), while cough, chest pain and loss of
weight were observed in 60%, 20% and 26.7% of cases
respectively.
In pleural effusion, breathing at a higher than normal chest
wall volume leads to making the inspiratory muscles operating
with abnormally low gain in converting a given neural input
into a mechanical output and respiratory discomfort would
arise from the recognition that the volume displacement
achieved is inappropriately small for the sense of effort made.
The decrease in the volume of the chest cavity after removal of
the pleural ﬂuid is associated with a lengthening of the inspira-
tory muscles at the end of expiration, placing these muscles on
a more advantageous portion of their length–tension curve and
allowing them to generate more pressure for the same or lesser
neural input [18]. The above data would provide an explana-
tion for dyspnea and improvement of dyspnea observed in
our studied cases following pleural ﬂuid drainage. The mean
amount of drained ﬂuid during thoracoscopy was
1.8 ± 0.8 L with a maximum of 3 and a minimum of 0.5 L.
Whereas, presence of parenchymal affection of the lung
especially in cases of interstitial lung disease or airway obstruc-
tion could be another contributing factors for dyspnea in our
studied cases.
Regarding radiographic study, plain X-ray and computed
tomography have been used in diagnosis of the studied cases.
Computed tomography provides cross-sectional images, two-
dimensional images that overcome the problems caused by
super-imposition of anatomic structures seen with chest radio-
graphs. It also permits a view of underlying parenchyma which
may be obscured by the pleural disease [19].Lung abnormalities with an increased density – also called
opacities practically are divided into four patterns:
– Consolidation
– Interstitial
– Nodules or masses
– Atelectasis
In this regard, the role of chest CT include conﬁrmation of
the pulmonary origin of the nodule, number of nodules, loca-
tion, size and determines its internal and edge characteristics,
coexisting abnormalities, as well as evaluation of the best
approach to biopsy [20]. With thin-slice chest-CT, the presence
of a spiculated edge, also called a corona radiata, has a positive
predictive value (PPV) range of 88–94% for malignancy, how-
ever, it may be seen in some benign lesions. A smooth contour,
on the other hand, is suggestive of a benign nature of the
lesion. However, up to a third of malignant nodules, especially
metastatic lesions, may have smooth margins, therefore, the
presence of a smooth contour is not a reliable sign. The pres-
ence of satellite lesions, tiny densities surrounding the primary
nodule, is a characteristic feature of granulomatous disease
and has a PPV of 90% for benign etiology. Administration
of intravenous contrast may be necessary in certain situations
to determine the enhancement of the nodule and/or to evaluate
the mediastinum for the presence of lymphadenopathy [20].
Furthermore CT chest prior to thoracoscopy is essential; as
detection of massive adhesions or complete lung collapse sec-
ondary to an endobronchial mass are considered con-
traindications to medical thoracoscopy [19,21,22]. Hence,
thoracoscopy could then be performed after relief of endo-
bronchial obstruction.
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HRCT, thoracoscopic examination revealed parietal pleural
lesions in the term of plaques, nodules or masses. Hence these
data signify that pleural involvement is possibly the responsi-
ble underlying cause of effusion in our studied cases.
In this study, before resorting to medical thoracoscopy as a
diagnostic tool, other diagnostic interventions were performed
but their results were inconclusive. Fiberoptic bronchoscopy
was done in three patients (20%), transthoracic ultrasound
guided biopsy in three patients (20%), while both procedures
were done in another three patients (20%).
Negative results can be accused to that: some of these
lesions were so peripheral, so they are out of reach of
Fiberoptic bronchoscopy, interstitial lung lesions required a
special type of bronchoscopic biopsy (transbronchial biopsy),
or inadequacy of ultrasound guided transthoracic needle
biopsies.
Preoperative evaluation is recommended since most com-
plications can be avoided by proper selection of patients for
thoracoscopy. Patients with severe chronic obstructive pul-
monary disease and consequent respiratory insufﬁciency, with
hypoxaemia (oxygen tension <60 mmHg) and hypercapnia,
will not tolerate induction of a pneumothorax without further
deterioration of the gas exchange, and therefore are not suit-
able candidates for thoracoscopy. When there is a contralat-
eral lung or pleural involvement, thoracoscopy is not
advisable, unless general anaesthesia and tracheal intubation
is used. Patients with an unstable cardiovascular status should
not undergo thoracoscopy. Any patient with a history of car-
diovascular disease should be evaluated by the cardiologist
before thoracoscopy.
Also, the need for thoracoscopy should be considered care-
fully in severe pulmonary ﬁbrosis as, after induction of a pneu-
mothorax, it can be difﬁcult to re-expand the lung due to the
loss of elasticity of the pulmonary tissue. Pulmonary biopsy
where honeycombing is present may result in prolonged leak-
age and impaired re-expansion of the lung. Pulmonary biopsy
should be avoided in hydatid cysts, arteriovenous mal-
formations and other highly vascularised lesions [13].
Regarding anaesthesia during medical thoracoscopy proce-
dure, the procedure can be done under general or local anaes-
thesia as stated by the European Respiratory society (ERS)
[14] depending on the indication and length of the procedure,
the severity of illness of the patient, as well as on the experience
of the physician and institutional biases. In our study, the pro-
cedure was performed under local anaesthesia and conscious
sedation except in only one patient who received general
anaesthesia because of the low pain threshold of the patient.
On the other hand, further studies used general anaesthesia
during the procedure [16,23,24]. Although general anaesthesia
facilitates application of the most available thoracoscopic
interventions, yet it would increase patients risks related to car-
diovascular complication [16,23,24]. Also, positive airway
pressure during general anaesthesia can increase the risk of
bronchopleural ﬁstula. Possibly it is due to inadequate sealing
of the cut surface of the visceral pleura by the electrocautery as
a result of positive pressure.
Thoracoscopic ﬁndings in the studied group of patients
demonstrated that the parietal pleura was affected in 6
(40%) patients showing nodules in 14 (93.3%) patients, pla-
ques in 2 (13.3%) patients, and masses in 3 (20%) patients.
Pleural effusion was traced in 6 (40%) patients, the meanamount of pleural ﬂuid drained is 1.8 ± 0.8 L. Adhesions were
found in 2 (13.3%) patients. The lung surface was affected in
all 15 (100%) patients showing nodules in 14 (93.3%) patients,
masses in 3 (20%) patients and anthracosis in 6 (40%)
patients.
Concerning number and size of forceps lung biopsies that
have been taken in the present study, a single biopsy was taken
in 33.3% of patients, two biopsies in 53.3% of patients and
three biopsies in 13.3% of patients. Inconclusive histopatho-
logical results were observed in cases with either single or
two biopsies.
The mean diameter of lung biopsies in our study was
3.68 ± 0.77 mm with a range of 2.1 mm–4.5 mm.
Comparable results regarding biopsy size were observed in
the study of Vansteenkiste et al. and Elnady et al. [25].
Vansteenkiste et al. (1999) performed medical rigid thora-
coscopy in 24 patients with interstitial lung diseases. Three
to ten lung biopsies were taken per patient, their mean diame-
ter was 3.95 ± 1.23 mm [8].
The study of Elnady et al. (2012) aimed to demonstrate the
safety, usefulness and feasibility of lung biopsy by medical thor-
acoscopy in patients with DPLDs on HRCT chest of uncon-
ﬁrmed diagnosis after evaluation with less invasive
investigations. Ten patients with DPLDs of unknown etiology
were included in their study,medical thoracoscopic lungbiopsies
were taken and sent for histopathologic examination. They
demonstrated that good biopsy specimens were obtained in all
patients with average size of biopsies of 0.5 ± 0.4 cm [25].
Whereas, Emam et al. (2012) performed experimental ani-
mal study to compare gross and microscopic features of deep
and subpleural pleuroscopic lung biopsy samples. The mean
number of biopsies taken per animal was 4.5 ± 1.22 and
4.83 ± 1.33 (p= 0.36) for deep and subpleural biopsies,
respectively. The mean size of deep and subpleural biopsies
was 1.758 ± 0.478 and 1.283 ± 0.851 cm2, respectively [26].
Difference between our study and those of others [8,26]
could be due to the differences regarding types of the studied
patients, technique of the biopsy procedure and experience.
This work is considered to be the ﬁrst attempt to perform
medical thoracoscopic lung biopsy in our department. To
our knowledge, in the literature only few studies have reported
experience in this ﬁeld.
During the thoracoscopic procedure, biopsies were taken
from the lung as well as from both lung and observed pleural
lesions in some of our studied cases (Case Nos. 1, 5, 7, 9, 10,
15). Pleural biopsies were also subjected to histopathological
study.
As regard the histopathological diagnosis of lung biopsies
in our study. Five cases (33.3%) were diagnosed as malignant
deposits. Two (13.3%) patients with bronchioloalveolar carci-
noma .Two (13.3%) patients had other types of bronchogenic
carcinoma. One of them had adenocarcinoma and the other
one had small cell lung cancer. Three (20%) cases showed
interstitial lung disease, two of them had cryptogenic organiz-
ing pneumonia and a single case had desquamative interstitial
pneumonia while, three (20%) cases demonstrated inconclu-
sive results.
In addition, histopathological study of the pleural biopsies
that revealed similar pathology to that of lung biopsies in
cases 1, 9, 10 demonstrated bronchogenic carcinoma signify-
ing that these pleural lesions were metastatic deposits, while
cases 5, 7, 15 showed pleural deposits of extrapulmonary
714 E. Hatata et al.malignancy but also with the same histopathology of lung
biopsies.
Vansteenkiste et al. (1999) performed thoracoscopic lung
biopsy for 24 patients with interstitial lung disease. They found
Pneumocystis carinii pneumonia, sarcoidosis, amyloidosis,
hypersensitivity pneumonitis, obliterated small arteries and
COP one patient for each. Two patients had lymphangitic
carcinomatosis, three patients had UIP, two patients had
DIP and two had LIP. A single patient showed normal lung
parenchyma out of 24 patients [8].
Krasna et al. (1995) performed VATS for twenty-four
patients with suspected interstitial lung diseases using a double
lumen tube and stapler technique for taking wedge shaped
biopsies. The pathologic ﬁndings for the resected specimens
were as follows: UIP seven patients, granulomas four patients,
Wegner’s granulomatosis three patients, BOOP two patients,
CMV pneumonia and LAM single patient for each [27].
Compared to the above studies, in this work different
radiological varieties were included (nodules, masses, intersti-
tial lung disease) versus only interstitial lung diseases in the
other studies [8,27]. This selection allows to study the validity
of thoracoscopic lung biopsies in the different radiological and
pathological lesions.
Results of this study provide evidence for the efﬁciency of
thoracoscopic lung biopsies in the diagnosis of different pul-
monary pathological lesions.
In our study, few complications were encountered in the
studied group of patients. Local wound infection was observed
in one patient (6.7%) and he was managed by frequent sterile
dressings, local antiseptic solution and local antibiotics, and all
cases resolved within 4–5 days. Subcutaneous emphysema was
encountered in 2 patients (16.4%) and resolved 1–2 days after
the procedure.
Compared to our results, Elnady et al. in their study of lung
biopsy by medical thoracoscopy in patients with DPLDs
reported persistent air leak for 5 and 7 days, pneumothorax
after removal of the intercostal tube, pain and minor bleeding
in 20%, 20%, 60% and 10% of patients respectively. They
concluded that the procedure is feasible and safe. It carries
some complications that are not life threatening and can be
minimized by a good selection of patients [23,7].
Prolonged air leak for more than 5 days was observed in
only one patient (6.7%) (Case No. 4). The air leak was not
related to number or size of biopsies, but it might be related
to positive pressure used during the general anaesthesia.
Instillation of saline over the sites of biopsy taking helped us
greatly to detect air leak at these sites and so allowed the use
of extra-coagulation after sampling. These intra-operative
techniques greatly help to decrease the incidence of air leak
at sites of biopsy sampling.
Compared to our results, in the study of Boutin et al. [28]
who performed medical thoracoscopic lung biopsies incases
with interstitial lung disease, a prolonged air-leak (>5 days)
was noted in three out (15%) of 20 patients with stiff lungs
and ﬁbrosis.
Whereas, Vansteenkiste et al. (1999) reported it in seven
patients (27%) out of 24 patients [8]. In the study of
Dijkman et al. [6], the mean duration of drainage was 4.5 days
(maximum 14) also in cases of interstitial lung disease using
medical thoracoscopy.
Randall et al. reported that it is difﬁcult to summarize the
overall complication rate because it depends on the indicationof thoracoscopy, type of anaesthesia, equipment used, patient
population, experience of the operator and adequacy of post
procedure care. These factors can explain the wide range of
variation in the reported incidence of post-thoracoscopic com-
plications [29].
Among factors that may contribute to persistent alveolar
air leaks [30] are the presence of preoperative risk factors
(increased age, male gender, COPD, steroid use, infections,
adhesions, apposition of pleura and lung surface) operative
techniques to reduce air leak, staple lines, handling of tissues,
and postoperative factors (chest tube management, and high
ventilation pressures).
In the present study, none of the studied case patients devel-
oped empyema. The reported incidence of empyema in the pre-
vious thoracoscopic studies varied from 0% in multiple studies
[15,31–34], 0.5% (5 of 1145 cases) [35], 0.6% (1 of 147 cases)
[36], 1% (6 of 556 cases) [37], 2% (4 of 182 cases) [29], 2.5%
(9 of 360 cases) [38], 4% (6 of 149 cases) [13], 4.8% (2 of 42
cases) [39] to 10% (3 of 30 cases) [40]. The difference in the
incidence of empyema in the different studies may be related
to the number of cases in each study (mostly noted that higher
incidence of empyema was recorded with studies performed on
a fewer number of cases), the adequacy of disinfection of the
ﬁeld of the procedure, the underlying cause of pleural effusion,
the availability of adequate antibiotic for an adequate duration
and the general condition of the patients.
In this study, one patient developed local wound infection
at the site of insertion of the intercostal tube. The incidence
of local wound infection was reported following thoracoscopy
in previous studies varied from 0% [34,41], 0.5% [35], 1%
[29], 1.5% [31], 7.1% (3 of 42 cases) [39] to 43.33%. [40]
Local wound infection is a small self limiting complication.
It requires local application of antiseptics and frequent
dressing changes. This could explain such a widely reported
range of incidence. Many operators would not bother to
report it.
In the present study, two (16.4%) patients developed surgi-
cal emphysema which may be due to wide pleural opening. The
incidence of surgical emphysema was reported following thor-
acoscopy in previous studies varying from 1.5% [31], 2% [43],
4% [42], 5.3% [13], 7% [44], 7.1% [39], 7.01% [37], 8% [29],
8.33% [14], 10% [34], 20% [15] to 23.33% [40] patients. This
difference in the incidence of surgical emphysema may be
related to size of the wound, tightness of the sutures and
experience of the operator. It is usually minimal in amount
and self limiting. Again, it is one of the minor complications
which could be easily ignored by the operator [36,45,46].Conclusions
Preoperative evaluation and proper selection of patient candi-
dates for medical thoracoscopy should be an integral part of
the procedure since this can avoid most of the complications.
It is convenient to perform medical thoracoscopy under local
anaesthesia and conscious sedation. Proper intraoperative pre-
cautions contributed signiﬁcantly in minimizing thoracoscopy
related complications. Our results provide circumstantial evi-
dence for the safety and efﬁciency of thoracoscopic forceps
Lung biopsy in the diagnosis of different lung lesions (diffuse
lung disease as well as localized lung lesions extending to
peripheral lung regions).
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